RESUMEN

Vitamin E is considered a powerful biological antioxidant; however, its characteristics such as high hydrophobicity and low stability limit its application. We propose to use nanotechnology as an innovative tool in spermatology, formulating nanoemulsions (NE) that accommodate vitamin E, protecting it from oxidation and promoting its release into the medium. The protective effect of the NE against oxidative stress was assessed in red deer epididymal sperm incubated at 37 °C. Cryopreserved sperm from eleven stags were thawed and extended to 400 × 106 sperm/ml in Bovine Gamete Medium (BGM). Once aliquoted, the samples were supplemented with the NE at different concentrations (0, 6 and 12 mM), with or without induced oxidative stress (100 µM Fe2+/ascorbate). The samples were evaluated after 0, 2 and 4 h of incubation at 37 °C. Motility (CASA), viability, mitochondrial membrane potential, acrosomal status, lipoperoxidation (C11 BODIPY 581/591), intracellular reactive oxygen species (ROS) production and DNA status (SCSA®) were assessed. After 2 and 4 h of incubation, the NE were able to prevent the deleterious effects of oxidative stress, thus improving total and progression motility (P ˂0.05). Moreover, the highest concentration tested (12 mM) improved almost every sperm kinematic variable (P ˂0.05) and preserved sperm viability in samples subjected to oxidative stress. In addition, 12 mM of NE protected the acrosomes integrity, maintained and protected mitochondrial activity, prevented sperm lipoperoxidation and reduced ROS production (P ˂0.05) in samples subjected to oxidative stress. This work indicates for the first time that vitamin E formulated in NE could be a new approach against sperm oxidative damage. This could be highly relevant for sperm physiology preservation in the context of assisted reproduction techniques.

Asunto(s)

Ciervos , Nanotecnología , Estrés Oxidativo , Motilidad Espermática , Vitamina E , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Humanos , Masculino , Especies Reactivas de Oxígeno/metabolismo , Reproducción , Espermatozoides/metabolismo , Vitamina E/metabolismo , Vitamina E/farmacología

RESUMEN

Current efforts on inflammatory bowel diseases (IBD) treatment are focused on strategies for localised drug delivery at the intestinal mucosa. Despite the potential of curcumin (CC) for IBD treatment, its low solubility and stability limit its application. Thus, the design of nanocarriers that focus CC delivery at the intestinal epithelium is an area of interest. This work proposes α-tocopherol nanoemulsions (NE) stabilised by ascorbyl-2,6-dipalmitate (ADP) as intestinal CC-carriers. The antioxidant capacity of α-tocopherol and ADP could have a synergistic effect on IBD-affected tissues, characterised by an oxidative environment. We obtained nanoemulsions (NE-ADP) with size below 200 nm, negative surface charge, stable in gastrointestinal media and no toxic in the Caco-2 cell model. Intracellular retention of NE-ADP in Caco-2 cells was observed by confocal microscopy. The extremely low Papp values obtained for CC and α-tocopherol indicated the lack of transport across the Caco-2 monolayer. Control nanoemulsion stabilised by lecithin (NE-L) was greatly transported across the Caco-2 cells monolayer, confirming the relevance of ADP on the cellular retention of NE-ADP. The therapeutic potential of NE-ADP was shown by the significant decrease of intracellular ROS levels. Altogether, these results indicate the potential of NE-ADP as a novel approach for the treatment of IBD.

Asunto(s)

Ácido Ascórbico/química , Curcumina/administración & dosificación , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Palmitatos/química , alfa-Tocoferol/administración & dosificación , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Transporte Biológico , Células CACO-2 , Curcumina/farmacología , Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos , Emulsiones , Humanos , Lecitinas/química , Nanopartículas , Tamaño de la Partícula , Especies Reactivas de Oxígeno/metabolismo , Solubilidad , alfa-Tocoferol/farmacología

RESUMEN

Nanoemulsions are vesicular systems with great potential for the delivery of drugs, which significantly depends on the appropriate selection of the components that constitute them. In this sense, the use of materials with adequate toxicity profiles for the oral route provides additional advantages in terms of safety concerns avoidance. This work describes the formulation of novel two-component nanoemulsions constituted by α-tocopherol and ascorbyl-palmitate derivatives. Among them, ascorbyl-dipalmitate allowed the formation of nanoemulsions with size values around 170 nm and negative charge; additionally, they showed strong antioxidant capacity. These nanoemulsions are proposed to the oral route, so their behaviour in intestinal conditions was evaluated by incubating the nanoemulsion in simulated intestinal fluid. This process led to the formation of an intestinal-protein corona (I-PC) at the colloidal surface that determined the interaction with the mucus barrier. The I-PC displaced the immobile-hindered particles towards a subdiffusive-diffusive population. These studies report for the first time the effect of the I-PC on the mucodiffusion behaviour of vesicular systems, a finding that may help to comprehend the performance of nanocarriers under intestinal conditions.

Asunto(s)

Ácido Ascórbico/análogos & derivados , Intestinos/química , Nanopartículas/química , Corona de Proteínas/química , Ácido Ascórbico/química , Difusión , Emulsiones/química , Tamaño de la Partícula , Propiedades de Superficie , alfa-Tocoferol/química

RESUMEN

Its high metabolic rate and high polyunsaturated fatty acid content make the brain very sensitive to oxidative damage. In the brain, neuronal metabolism occurs at a very high rate and generates considerable amounts of reactive oxygen species and free radicals, which accumulate inside neurons, leading to altered cellular homeostasis and integrity and eventually irreversible damage and cell death. A misbalance in redox metabolism and the subsequent neurodegeneration increase throughout the course of normal aging, leading to several age-related changes in learning and memory as well as motor functions. The neuroprotective function of antioxidants is crucial to maintain good brain homeostasis and adequate neuronal functions. Vitamins E and C are two important antioxidants that are taken up by brain cells via the specific carriers αTTP and SVCT2, respectively. The aim of this study was to use immunohistochemistry to determine the distribution pattern of these vitamin transporters in the brain in a mouse model that shows fewer signs of brain aging and a higher resistance to oxidative damage. Both carriers were distributed widely throughout the entire brain in a pattern that remained similar in 4-, 12-, 18- and 24-month-old mice. In general, αTTP and SVCT2 were located in the same regions, but they seemed to have complementary distribution patterns. Double-labeled cell bodies were detected only in the inferior colliculus, entorhinal cortex, dorsal subiculum, and several cortical areas. In addition, the presence of αTTP and SVCT2 in neurons was analyzed using double immunohistochemistry for NeuN and the results showed that αTTP but not SVCT2 was present in Bergmann's glia. The presence of these transporters in brain regions implicated in learning, memory and motor control provides an anatomical basis that may explain the higher resistance of this animal model to brain oxidative stress, which is associated with better motor performance and learning abilities in old age.

Asunto(s)

Envejecimiento/metabolismo , Encéfalo/metabolismo , Proteínas Portadoras/metabolismo , Estrés Oxidativo , Transportadores de Sodio Acoplados a la Vitamina C/metabolismo , Animales , Antígenos Nucleares/metabolismo , Antioxidantes/metabolismo , Ácido Ascórbico/metabolismo , Biomarcadores/metabolismo , Encéfalo/diagnóstico por imagen , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica/métodos , Aprendizaje , Masculino , Memoria , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas del Tejido Nervioso/metabolismo , Neuroglía/metabolismo , Neuroglía/ultraestructura , Neuronas/metabolismo , Neuronas/ultraestructura , Vitamina E/metabolismo

RESUMEN

Since the past decade, there has been growing interest to grant nanoparticles with diffusion properties across mucosae. In this sense, the nonionic block copolymer Pluronic F127 (PF127) has emerged as a promising coating agent to formulate mucus-penetrating particles. In the journey to find efficient coating agents, researchers have focused more on the effect of the coating agent architecture rather than on the role of the physicochemical properties of the nanoparticle used as the substrate. The current knowledge about mucodiffusive particles is in general based on model-like nanoparticles, such as polystyrene or poly(lactic-co-glycolic) acid nanoparticles, but there is a lack of information about the potential of PF127 on other colloidal systems. This work aims to shed some light on this issue by selecting three oils, palm (solid), coconut (semisolid), and wheat germ (liquid), with different physicochemical properties to formulate PF127-coated nanoemulsions. The obtained nanoemulsions were characterized, and their colloidal stability was tested. Their diffusion capacity was determined by particle tracking after challenging the nanoemulsions across an intestinal porcine mucus layer. In accordance with the evidence of model-like nanoparticles, our results state that PF127 allows mucodiffusion, but its effectiveness as a coating agent clearly depends on the physicochemical properties of the nanostructure core over which PF127 is placed. Among other physicochemical properties, the results certainly showed that the hydrophobic character of the nanostructure core emerges as a critical factor in the formulation of successful PF127 coatings.

Asunto(s)

Emulsiones/química , Excipientes/química , Nanopartículas/química , Poloxámero/química , Tensoactivos/química , Administración Oral , Animales , Aceite de Coco/química , Difusión , Estabilidad de Medicamentos , Concentración de Iones de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Moco/química , Aceite de Palma/química , Pancreatina/química , Tamaño de la Partícula , Pepsina A/química , Aceites de Plantas/química , Porcinos , alfa-Tocoferol/química

RESUMEN

This work is about improvement of a maceration method in order to achieve a green process for the enrichment of virgin olive oil (VOO) with natural antioxidants, specifically from oregano leaves. This goal was accomplished after evaluating different mechanical methods, i.e. magnetic stirring, sonication, vertical stirring and sonication in combination with vertical stirring, for promoting the extraction of the antioxidants from oregano. The results obtained indicated that the best extraction procedure was vertical stirring at 1000 r.p.m. for 3 h. Therefore, these conditions were selected to enrich VOO with phenolic acids (mainly rosmarinic acid) and endogenous antioxidants (o-coumaric and vanillic acids), and further determine their stability at room temperature or under temperature stress (50°C) during 45 days. Quantitative analysis of rosmarinic, o-coumaric and vanillic acids was carried out by an off-line, solid phase extraction, capillary zone, electrophoresis method combined with diode-array detector (SPE-CE-DAD).

Asunto(s)

Antioxidantes/análisis , Aditivos Alimentarios/análisis , Aceite de Oliva/química , Origanum/química , Extractos Vegetales/análisis , Cinamatos/análisis , Depsidos/análisis , Hidroxibenzoatos/análisis , Hojas de la Planta/química , Ácido Rosmarínico

RESUMEN

Most frequently the use of bioactive molecules for the supplementation of food and beverages is hampered by stability limitations or inadequate intestinal absorption. This work evaluates in vitro the role that the interface of the nanoemulsion has on the physicochemical properties, the stability behavior and the enzymatic degradation after oral intake. For that purpose three soybean oil (SB) formulations were studied. These formulations were based on the emulsifier lecithin but modified with two non-ionic surfactants Pluronic(®) F68 (PF68) or Pluronic(®) F127 (PF127) yielding (i) SB-NE (only lecithin on the interface), (ii) SB-NE PF68 (lecithin plus PF68) and 9 (iii) SB-NE PF127 (lecithin plus PF127). All the formulations tested were low polydispersed and showed a size of about 200 nm and ζ-potential of -50 mV. The in vitro colloidal stability assay showed that lecithin itself was able to promote that formulations reach unaltered to the small intestine and facilitate the absorption of the antioxidant payload on a tunable fashion there (with in vitro bioaccessibility values from around 40% up to a 70%). PF68 was able to sterically stabilize the formulation against the aggregation induced by the pH and electrolytes of the simulated gastrointestinal track; however, this surfactant was easily displaced by the lipases of the simulated intestinal milieu being unable to modulate the digestion pattern of the oil droplets in the small intestine. Finally, PF127 displayed a strong steric potential that dramatically reduced the interaction of the oil droplets with lipases in vitro, which will compromise the capacity of the formulation to improve the bioaccessibility of the loaded antioxidant.

Asunto(s)

Antioxidantes/química , Emulsiones/química , Nanopartículas/química , Fármacos Neuroprotectores/química , Disponibilidad Biológica , Química Farmacéutica/métodos , Portadores de Fármacos/química , Emulsionantes/química , Lecitinas/química , Tamaño de la Partícula , Aceite de Soja/química

RESUMEN

We have previously demonstrated in a therapeutic study that a single systemic course of DAB-Am16 dendriplexes loaded with plasmid expressing TNFα over a period of time of 10 days led to a regression of 100% of tumours and to long term cures of up to 80% of animals. However, the formulation had a relatively low colloidal stability requiring administration soon after nanoparticle preparation. Similar to other cationic polyplex and dendrimer DNA delivery systems, DAB-AM16 dendrimer formulations contained a substantial proportion of free polymer; this free polymer is present independently of the specific polymer:DNA ratio and increases with increasing proportion of polymer (N:P charge ratio) in the formulation. It has previously been shown for this and other systems that the excess of polymer plays a role in promoting the transfection efficiency of synthetic vectors. This has been linked to effects of the polymer on the efficiency of intracellular processing, e.g. endosomal release. However, the free polymer may have additional effects that are relevant to the efficiency of the formulation. This study therefore considered the effect of free dendrimer on the colloidal stability of the complexes, the interaction of the complex with the formulation medium, and with biological components, i.e. electrolytes and serum proteins after administration. Analysis of the total potential of interaction shows that, even at high N:P ratios, the excess of free dendrimer in the medium is not enough to induce the aggregation of the formulation due to depletion forces. This finding is unusual and can be attributed to the particularly low Mw of these dendrimers (1.6 kDa). On the other hand, formulations are highly sensitive to the strength of the dendrimer:DNA interactions. These can be controlled by the degree of protonation (α) of the dendrimer which is strongly dependent on bulk pH. Modulation of the protonation level to α≥0.4 allows reproducible production of colloidally stable particles. Finally, we have demonstrated that electrolytes and proteins present in physiological media play a crucial role to favour the efficiency of these synthetic vectors reducing the toxicity associated with their cationic groups.

Asunto(s)

Dendrímeros/metabolismo , Sistemas de Liberación de Medicamentos , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Neoplasias/genética , Neoplasias/terapia , Polipropilenos/metabolismo , Cationes/química , Cationes/metabolismo , Línea Celular Tumoral , Dendrímeros/síntesis química , Dendrímeros/química , Humanos , Polipropilenos/química

RESUMEN

In recent years, chitosan nanocapsules have shown promising results as carriers for oral drug or peptide delivery. The success in their applicability strongly depends on the stability of these colloidal systems passing through the digestive tract. In gastric fluids, clear stability comes from the high surface charge density of the chitosan shell, which is completely charged at acidic pH values. However, in the intestinal fluid (where the pH is almost neutral) the effective charge of these nanocapsules approaches zero, and the electrostatic forces cannot provide any stabilization. Despite the lack of surface charge, chitosan nanocapsules remain stable in simulated intestinal fluids. Recently, we have demonstrated that this anomalous stability (at zero charge) is owed to short-range repulsive forces that appear between hydrophilic particles when immersed in saline media. The present work examines the influence of the chitosan hydrophobicity, as well as molecular weight, in the stability of different chitosan nanocapsules. A study has been made of the size, polydispersity, electrophoretic mobility, and colloidal stability of eight core-shell nanocapsule systems, in which the chitosan-shell properties have been modified using low-molecular-weight (LMW) and high-molecular-weight (HMW) chitosan chains having different degrees of acetylation (DA). With regard to the stability mediated by repulsive hydration forces, the LMW chitosan provided the best results. In addition, contrary to initial expectations, greater stability (also mediated by hydration forces) was found in the samples formed with chitosan chains of high DA values (i.e. with less hydrophilic chitosan). Finally, a theoretical treatment was also tested to quantify the hydrophilicity of the chitosan shells.

Asunto(s)

Quitosano/química , Nanocápsulas/química , Nanotecnología/métodos , Administración Oral , Líquidos Corporales/metabolismo , Coloides/química , Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos , Concentración de Iones de Hidrógeno , Mucosa Intestinal/metabolismo , Cinética , Peso Molecular , Tamaño de la Partícula , Polímeros/química , Electricidad Estática

RESUMEN

The goal of this paper was aimed to the formulation of nanoparticles by using two different propyl-starch derivatives - referred to as PS-1 and PS-1.45 - with high degrees of substitution: 1.05 and 1.45 respectively. A simple o/w emulsion diffusion technique, avoiding the use of hazardous solvents such as dichloromethane or dimethyl sulfoxide, was chosen to formulate nanoparticles with both polymers, producing the PS-1 and PS-1.45 nanoparticles. Once the nanoparticles were prepared, a deep physicochemical characterization was carried out, including the evaluation of nanoparticles stability and applicability for lyophilization. Depending on this information, rules on the formation of PS-1 and PS-1.45 nanoparticles could be developed. Encapsulation and release properties of these nanoparticles were studied, showing high encapsulation efficiency for three tested drugs (flufenamic acid, testosterone and caffeine); in addition a close to linear release profile was observed for hydrophobic drugs with a null initial burst effect. Finally, the potential use of these nanoparticles as transdermal drug delivery systems was also tested, displaying a clear enhancer effect for flufenamic acid.

Asunto(s)

Portadores de Fármacos/química , Nanopartículas/química , Preparaciones Farmacéuticas/administración & dosificación , Almidón/análogos & derivados , Almidón/química , Administración Cutánea , Tampones (Química) , Células CACO-2 , Cafeína/administración & dosificación , Supervivencia Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Portadores de Fármacos/síntesis química , Portadores de Fármacos/toxicidad , Composición de Medicamentos , Estabilidad de Medicamentos , Femenino , Ácido Flufenámico/administración & dosificación , Humanos , Técnicas In Vitro , Nanopartículas/toxicidad , Piel/efectos de los fármacos , Piel/metabolismo , Absorción Cutánea/efectos de los fármacos , Solubilidad , Solventes/química , Almidón/síntesis química , Almidón/toxicidad , Testosterona/administración & dosificación

RESUMEN

The aim of this work was to study poly(d,l-lactic-co-glycolic) acid (PLGA) nanoparticles--formulated by a modified solvent diffusion technique--applied as model nanocarriers for insulin in potential oral administrations. These nanostructures consisted of a blend matrix formed by PLGA copolymer and polyoxyethylene derivatives. Two types of blend formulations, PLGA:poloxamer (Pluronic F68) and PLGA:poloxamine (Tetronic T904), were analyzed, and the results compared to those obtained with pure PLGA nanoparticles. The work has been divided into two parts. (a) Firstly, the stability of the unloaded nanoparticles in simulated gastric and intestinal fluids was studied. Degradation studies reflected a strong interaction between the pure PLGA nanoparticles and the digestive enzymes. However, this interaction was considerably reduced in the blend formulations, although the PLGA:poloxamine system became colloidally unstable in the simulated gastric fluid. (b) Secondly, the effect of the net charge of the encapsulated macromolecule in the final properties of the blend formulations was studied by encapsulating insulin below and above its corresponding isoelectric point. The net charge of the encapsulated protein showed a clear effect in the final size of the nanoparticles, while the encapsulation efficiency was controlled by the polyoxyethylene derivative presents in the blend formulation. The obtained results show that those carriers formed with encapsulated insulin in PLGA-Pluronic F68 particles are capable, at least in vitro, to overcome the gastrointestinal barrier. Therefore, these nanocarriers seem to be appropriate for oral administration of insulin, although performing in vivo studies becomes necessary to corroborate such statement.

Asunto(s)

Portadores de Fármacos/química , Jugo Gástrico/química , Insulina/administración & dosificación , Insulina/química , Secreciones Intestinales/química , Ácido Láctico/química , Nanopartículas/química , Ácido Poliglicólico/química , Titanio/química , Administración Oral , Materiales Biomiméticos/química , Portadores de Fármacos/administración & dosificación , Contenido Digestivo/química , Humanos , Ensayo de Materiales , Nanopartículas/ultraestructura , Tamaño de la Partícula , Copolímero de Ácido Poliláctico-Ácido Poliglicólico

RESUMEN

Drug delivery systems based on polymeric nanocarriers have been widely exploited during the last years. However, one of the basic problems that is still not totally solved in this kind of systems is the ability of delivering drugs to specific target cells. Coating the nanocarrier with reactive antibodies against specific molecules presented in the external membrane of the target cells is a usual recommendation. In this paper, an ideal delivery system has been studied. Nanoparticles made of poly(d,l-lactic acid/glycolic acid) 50/50 (PLGA) polymers have been coated with polyclonal IgG. In the first part of the paper, some basic characteristics of these IgG-PLGA complexes have been analysed (i.e. size, electrophoretic mobility and colloidal stability). Then, the immunoreactivity of the immobilized IgG molecules was tested by using an optical device, monitoring the binding of a standard molecule (C-reactive protein, CRP) to the antibody (antiCRP-IgG) adsorbed on the PLGA particles. This allowed us to estimate the percentage of active IgG molecules on the PLGA particles by applying a simple kinetic model to the immunoreactivity results. According to this model, the PLGA-IgG particles supply a good immunoresponse even if only less than 5% of the total IgG molecules on the surface were active. Despite the simplicity of the system, the results may be of potential interest for developing more realistic nanocarriers with targeting ability. That is, it can be inferred that it is possible to obtain a high targeting specificity in IgG-sensitized nanocarriers even working with a low coverage of active antibody molecules. The results have been compared with those similarly obtained with polystyrene (PS) particles used as a reference system.

Asunto(s)

Inmunoglobulina G/química , Ácido Láctico/química , Ácido Poliglicólico/química , Polímeros/química , Proteína C-Reactiva/inmunología , Coloides , Electroforesis , Inmunoensayo , Inmunoglobulina G/metabolismo , Nanopartículas/química , Copolímero de Ácido Poliláctico-Ácido Poliglicólico

RESUMEN

Poloxamers are a family of polypropylene oxide (PPO) and polyethylene oxide (PEO) tri-block copolymers that are usually employed in the micro- and nanoparticulate engineering for drug delivery systems. The aim of this work is to study the electrophoretic mobility (mu(e)) and colloidal stability of complexes formed by adsorbing a poloxamer (Pluronic F68) onto poly(d,l-lactic-co-glycolic acid) (PLGA) nanoparticles. A variety of stabilisation mechanisms have been observed for the Pluronic-coated PLGA nanoparticles, where DLVO interactions, solvent-polymer segment interactions and hydration forces play different roles as a function of the adsorbed amount of Pluronic. In addition, the mu(e) and stability data of these complexes have been compared to those obtained previously using a PLGA-Pluronic F68 blend formulation. As both the mu(e) and the stability data are identical between the two systems, a phase separation of both components in the PLGA-Pluronic blend formulation is suggested, being the PLGA located in the core of the particles and the Pluronic in an adsorbed shell.

Asunto(s)

Ácido Láctico/química , Nanopartículas/química , Poloxámero/química , Ácido Poliglicólico/química , Polímeros/química , Adsorción , Cloruro de Calcio/química , Coloides , Concentración de Iones de Hidrógeno , Estructura Molecular , Tamaño de la Partícula , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Cloruro de Sodio/química , Propiedades de Superficie